Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Artificial Intelligence (AI) In Respiratory Diseases Market Forecast Highlighting Growth From $8.37 Billion To $10.19 Billion

The market for artificial intelligence in respiratory diseases has experienced consistent expansion, projecting an increase from $7.98 billion in 2025 to $8.38 billion in 2026, reflecting a compound annual growth rate of 4.9%. Key factors driving this historical growth include the escalating prevalence of respiratory conditions, broader utilization of CT and MRI scans, the increasing digitization of patient health records, the early integration of AI in diagnostic support, and the enhancement of diagnostic capacities within healthcare facilities.

The market for artificial intelligence (AI) applied to respiratory ailments is poised for substantial expansion over the upcoming years, projected to reach a valuation of $10.19 billion by 2030, experiencing a compound annual growth rate (CAGR) of 5.0%. This anticipated growth is primarily fueled by several key factors: a heightened need for customized respiratory care approaches, the growing incorporation of AI into clinical decision-making frameworks, the broader implementation of remote patient monitoring for individuals with chronic respiratory conditions, an intensified emphasis on proactive pulmonology, and significant strides in AI-powered medical imaging. Several prominent trends are expected to shape this market during the forecast period, including a greater utilization of AI-driven image analysis techniques, an increased acceptance of models that predict disease progression, augmented integration of AI within the realm of pulmonary diagnostics, the proliferation of remote monitoring solutions for respiratory health, and a stronger focus on identifying diseases at their earliest stages.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

#Artificial Intelligence (AI) In Respiratory Diseases Market Demand Drivers Creating New Revenue Opportunities

The trajectory of the respiratory disease market is being shaped by environmental pollution, defined as the introduction of substances or energy into the environment at a pace exceeding its capacity for safe dispersion or storage. Artificial intelligence holds considerable promise for mitigating the adverse effects of environmental pollution on respiratory well-being, providing capabilities such as continuous monitoring, tailored risk evaluations, evidence-based decision-making, and novel approaches for both individuals and collective populations. Illustrating this, global fossil carbon dioxide emissions reached 37.4 billion tonnes in November 2024, marking a 0.8% rise from the prior year, as reported by the annual Global Carbon Budget assessment originating from Japan. Consequently, the escalating levels of environmental pollution are a significant catalyst for the expansion of artificial intelligence applications within the respiratory disease sector.

Artificial Intelligence (AI) In Respiratory Diseases Market Segment Performance And Strategic Opportunities

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Artificial Intelligence (AI) In Respiratory Diseases Market Trends Driving Strategic Industry Expansion

Leading entities within the artificial intelligence (AI) sphere for the respiratory disease sector are actively engaged in creating cutting-edge solutions like N-Tidal devices, designed for the continuous observation of a patient’s resting breath patterns. This N-Tidal apparatus quantifies the volume of air inhaled and exhaled during regular respiration, thereby furnishing crucial insights into pulmonary efficiency. Illustrating this, in August of 2023, TidalSense, a respiratory innovation firm based in the United Kingdom, introduced N-Tidal, an AI-powered technology that has received regulatory approval for the identification and ongoing care of chronic obstructive pulmonary disease (COPD). This technology synthesizes the carbon dioxide sensor readings from N-Tidal with an associated artificial intelligence framework to meticulously track alterations in lung performance, with the ultimate goal of enhancing both the diagnosis and therapeutic strategies for this particular respiratory ailment. Evidence from clinical investigations has substantiated the remarkable precision of this technology, and it is anticipated to revolutionize the conventional methods for diagnosing respiratory conditions. This product introduction represents a pivotal advancement in the application of AI for the evaluation of respiratory illnesses, presenting a less intrusive and more streamlined option compared to the diagnostic procedures currently in use.

Artificial Intelligence (AI) In Respiratory Diseases Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd

Access The Complete Artificial Intelligence (AI) In Respiratory Diseases Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

#Artificial Intelligence (AI) In Respiratory Diseases Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model